Non-progressive Late-onset Linear Hemifacial Lipoatrophy

Non-progressive late-onset linear hemifacial lipoatrophy is a rare condition that affects the face, causing a localized loss of fat in one half of the face. The condition is characterized by a linear depression in the subcutaneous tissue along the cheek, jaw, or temporal region. It is considered non-progressive because it does not worsen over time, and late-onset because it usually occurs after the age of 40.

There are several types of non-progressive late-onset linear hemifacial lipoatrophy, including:

1. Unilateral facial lipoatrophy: This is the most common type of non-progressive late-onset linear hemifacial lipoatrophy and affects only one side of the face.
2. Bilateral facial lipoatrophy: This type affects both sides of the face, but the extent of the loss of fat may be different on each side.
3. Temporal lipoatrophy: This type affects the temporal region and is characterized by a linear depression in the subcutaneous tissue along the temple.
4. Jugal lipoatrophy: This type affects the cheek and jaw, causing a linear depression in the subcutaneous tissue along the cheek and jawline.

Causes

The exact cause of NPLLH is not known, but there are several factors that have been associated with its development. Here, we will discuss  causes of NPLLH:

1. Autoimmune disorders: There is evidence that NPLLH may be associated with autoimmune disorders, such as systemic lupus erythematosus (SLE) and scleroderma. In these conditions, the immune system attacks the body’s own tissues, including the subcutaneous fat tissue of the face.
2. Trauma: Trauma to the face, such as a blow or injury to the face, has been associated with the development of NPLLH. It is believed that trauma may trigger an immune response that leads to the loss of facial fat.
3. Infection: Some infections, such as Lyme disease and herpes simplex virus, have been associated with the development of NPLLH. It is believed that the infection triggers an immune response that leads to the loss of facial fat.
4. Radiation therapy: Radiation therapy for cancer treatment has been associated with the development of NPLLH. It is believed that the radiation damages the subcutaneous fat tissue of the face, leading to its loss.
5. Genetics: NPLLH may be inherited in some cases. Several genes have been implicated in the development of NPLLH, including the HLA system, which plays a role in the immune response.
6. Hormonal imbalances: Hormonal imbalances, such as those seen in polycystic ovary syndrome (PCOS), have been associated with the development of NPLLH. It is believed that the hormonal imbalances may trigger an immune response that leads to the loss of facial fat.
7. Nutritional deficiencies: Nutritional deficiencies, such as vitamin E deficiency, have been associated with the development of NPLLH. It is believed that the deficiency may lead to damage to the subcutaneous fat tissue of the face.
8. Medications: Some medications, such as anticonvulsants, have been associated with the development of NPLLH. It is believed that the medications may trigger an immune response that leads to the loss of facial fat.
9. Connective tissue disorders: Connective tissue disorders, such as Marfan syndrome and Ehlers-Danlos syndrome, have been associated with the development of NPLLH. It is believed that the abnormal connective tissue may lead to damage to the subcutaneous fat tissue of the face.
10. Autoinflammatory disorders: Autoinflammatory disorders, such as CANDLE syndrome and SAVI syndrome, have been associated with the development of NPLLH. In these conditions, the immune system is activated without infection or other external trigger.
11. Environmental toxins: Exposure to environmental toxins, such as heavy metals, has been associated with the development of NPLLH. It is believed that the toxins may lead to damage to the subcutaneous fat tissue of the face.
12. Migraine: Migraine headaches have been associated with the development of NPLLH. It is believed that the headaches may trigger an immune response that leads to the

Symptoms

Here are the symptoms of NPLLHL and their details explained in words.

1. Unilateral facial lipoatrophy – The primary symptom of NPLLHL is the loss of subcutaneous fat on one side of the face. This is usually a linear pattern that follows a specific course.

The fat loss in NPLLHL usually affects the upper or lower half of the face, and it is unilateral, which means it only affects one side of the face. The line of demarcation between the affected and unaffected areas is usually sharp, and the loss of fat can be quite dramatic.

2. Asymmetry of the face – The loss of fat in NPLLHL can cause the face to appear asymmetrical. This can be particularly noticeable when the affected individual smiles or frowns.
3. Sunken temples – The temples on the affected side of the face may appear sunken due to the loss of fat.
4. Hollowed cheeks – The loss of subcutaneous fat can also cause the cheeks to appear hollowed or sunken.
5. Deep nasolabial fold – The nasolabial fold is the line that runs from the nose to the corner of the mouth. In NPLLHL, this fold can become deeper on the affected side of the face.
6. Loss of buccal fat pad – The buccal fat pad is a structure in the cheek that provides cushioning and support. In NPLLHL, the buccal fat pad on the affected side of the face may be significantly reduced.
7. Facial asymmetry worsens with age – The asymmetry of the face in NPLLHL may worsen with age, as the loss of fat becomes more noticeable.
8. No associated pain – Unlike some other facial conditions, NPLLHL is not associated with pain.
9. No associated sensory changes – NPLLHL does not typically cause any changes in sensation on the affected side of the face.
10. No associated muscle weakness – NPLLHL does not typically cause any weakness in the facial muscles.
11. No associated vision changes – NPLLHL does not typically cause any changes in vision.
12. No associated hearing changes – NPLLHL does not typically cause any changes in hearing.
13. No associated neurological symptoms – NPLLHL is not associated with any other neurological symptoms.
14. No associated systemic symptoms – NPLLHL is not associated with any other systemic symptoms.
15. No associated skin changes – NPLLHL is not associated with any changes in the skin on the affected side of the face.
16. No associated hair changes – NPLLHL is not associated with any changes in the hair on the affected side of the face.
17. No associated dental changes – NPLLHL is not associated with any changes in the teeth or gums on the affected side of the face.
18. No associated eye changes – NPLLHL is not associated with any changes in the eyes on the affected side of the face.
19. No associated changes in speech or swallowing – NPLLHL is not associated with any changes in speech or swallowing.
20. No associated changes in mood or cognition – NPLLHL is not associated with any changes in mood or cognition.

While the loss of fat in NPLLHL can be quite noticeable and may cause significant cosmetic concerns, the condition is typically

Diagnosis

Here is a list of  diagnoses and tests used in the evaluation and management of NPLL:

1. Clinical evaluation: The diagnosis of NPLL is based on the characteristic clinical presentation of a linear loss of subcutaneous fat on one side of the face. The affected area may be sunken or depressed and may be associated with a mild degree of asymmetry.
2. Biopsy: A skin biopsy can confirm the diagnosis of NPLL. The biopsy shows a decrease in subcutaneous adipose tissue on the affected side of the face.
3. Blood tests: Blood tests can be done to rule out other autoimmune disorders, such as lupus, scleroderma, and dermatomyositis, which may present with similar clinical features.
4. Imaging studies: Imaging studies such as CT scans, MRIs, or ultrasounds can be done to evaluate the extent and severity of the subcutaneous fat loss and to rule out other conditions, such as tumors.
5. Electromyography (EMG): EMG can be used to assess the function of the facial muscles and to rule out any underlying neuromuscular disorders.
6. Biopsy of other affected sites: In rare cases, NPLL can also affect other parts of the body, such as the trunk or extremities. A biopsy of other affected sites can be done to confirm the diagnosis.
7. Histopathological examination: A histopathological examination of the biopsy specimen can reveal characteristic changes, such as a decrease in the number and size of adipocytes and fibrosis of the connective tissue.
8. Immunohistochemistry: Immunohistochemistry can be done to evaluate the expression of various markers of inflammation, such as CD4, CD8, and CD68.
9. Skin surface microscopy: Skin surface microscopy can be used to evaluate the skin texture and pigmentation and to rule out any underlying skin conditions, such as vitiligo or morphea.
10. Skin thickness measurement: Skin thickness measurement can be used to evaluate the degree of subcutaneous fat loss and to monitor disease progression.
11. Ultrasonography: Ultrasonography can be used to visualize the subcutaneous fat layer and to evaluate the degree of fat loss.
12. Magnetic resonance spectroscopy: Magnetic resonance spectroscopy can be used to evaluate the biochemical composition of the subcutaneous fat layer and to monitor disease progression.
13. Lipid profile: Lipid profile can be done to evaluate the levels of various lipids, such as triglycerides and cholesterol, which may be altered in patients with NPLL.
14. Glucose tolerance test: A glucose tolerance test can be done to evaluate insulin sensitivity and to rule out any underlying metabolic disorders, such as diabetes mellitus.
15. Thyroid function tests: Thyroid function tests can be done to evaluate thyroid function and to rule out any underlying thyroid disorders, which may present with similar clinical features.
16. Autoantibody screening: Autoantibody screening can be done to evaluate the presence of autoantibodies, such as antinuclear antibodies (ANA), anti-dsDNA antibodies, and anti-Ro/La antibodies, which may be present in patients with autoimmune disorders.
17. Skin prick test: A skin prick test can be done to evaluate the allergic response and to rule out any underlying allergic disorders, which may present with similar clinical features.

Treatment

Treatments of non-progressive late-onset linear hemifacial lipoatrophy in detail.

1. Facial filler injections: Facial filler injections can help plump up the affected area by injecting materials such as hyaluronic acid, collagen, or autologous fat into the affected area. The procedure is typically done on an outpatient basis, and the results can last for several months to years, depending on the type of filler used.
2. Autologous fat transfer: Autologous fat transfer involves the removal of fat tissue from another part of the body, such as the abdomen or thighs, and transplanting it to the affected area. This procedure requires general anesthesia and can take several hours to complete. The results can be long-lasting, but the success of the procedure depends on the amount of fat that is transplanted and the body’s ability to absorb the transplanted tissue.
3. Platelet-rich plasma (PRP) injections: Platelet-rich plasma (PRP) is derived from a patient’s own blood and is rich in growth factors that can stimulate tissue regeneration. PRP injections are commonly used in sports medicine and orthopedics to promote healing, but they can also be used in dermatology to stimulate tissue regeneration in the affected area.
4. Laser therapy: Laser therapy involves the use of high-energy light to stimulate collagen production and promote tissue regeneration. Different types of lasers can be used, including fractional lasers and intense pulsed light (IPL) therapy. Laser therapy can help reduce the appearance of atrophy and improve the texture and tone of the skin.
5. Microneedling: Microneedling involves the use of tiny needles to create microchannels in the skin, which can stimulate collagen production and promote tissue regeneration. Microneedling can help improve the texture and tone of the skin and reduce the appearance of atrophy.
6. Topical corticosteroids: Topical corticosteroids can be used to reduce inflammation in the affected area and improve the appearance of atrophy. However, long-term use of topical corticosteroids can lead to skin thinning and other side effects.
7. Topical tacrolimus: Topical tacrolimus is an immunosuppressant that can be used to reduce inflammation in the affected area. It can also help improve the appearance of atrophy, but its long-term safety has not been established.
8. Topical calcipotriol: Topical calcipotriol is a vitamin D analog that can be used to stimulate tissue regeneration in the affected area. It can also help improve the appearance of atrophy, but its long-term safety has not been established.
9. Retinoids: Retinoids are derivatives of vitamin A that can help improve the appearance of atrophy by stimulating collagen production and promoting tissue regeneration. However, long-term use of retinoids can lead to skin irritation and other side effects.
10. Silicone implants: Silicone implants can be used to fill in the affected area and improve the appearance of atrophy. However, the success of the procedure depends on the size and shape of the implant, and complications such as infection and implant migration can occur.
11. Dermal fillers: One of the most common treatments for NPLL is the use of dermal fillers to restore volume to the affected area. Hyaluronic acid fillers are commonly used, as they are biocompatible and can be easily molded to create a natural-looking contour. The results of dermal filler treatments typically last for several months to a year, depending on the product used.
12. Fat grafting: Fat grafting involves harvesting fat from one area of the body and transferring it to the affected area. This procedure can be effective for restoring volume and contour to the face, but it is more invasive than dermal fillers and requires a longer recovery time.
13. Sculptra: Sculptra is a collagen stimulator that is injected into the skin to stimulate the body’s natural collagen production. The treatment requires multiple sessions over a period of several months, but the results can last for up to two years.
14. Platelet-rich plasma (PRP): PRP involves the injection of a patient’s own platelet-rich plasma into the affected area. This treatment can stimulate the growth of new tissue and improve the appearance of the skin.
15. Laser therapy: Laser therapy can be used to stimulate collagen production and improve the texture and appearance of the skin. This treatment can be effective for NPLL, but multiple sessions may be required to achieve optimal results.
16. Micro-needling: Micro-needling involves the use of a device with tiny needles to create micro-injuries in the skin. This can stimulate collagen production and improve the texture and appearance of the skin.
17. Chemical peels: Chemical peels involve the application of a chemical solution to the skin to remove the outer layer of dead skin cells. This can improve the texture and appearance of the skin and stimulate collagen production.
18. Radiofrequency therapy: Radiofrequency therapy uses heat energy to stimulate collagen production and improve the appearance of the skin. This treatment can be effective for NPLL, but multiple sessions may be required to achieve optimal results.
19. Ultrasound therapy: Ultrasound therapy uses sound waves to stimulate collagen production and improve the appearance of the skin. This treatment can be effective for NPLL, but multiple sessions may be required to achieve optimal results.
20. Cryotherapy: Cryotherapy involves the use of extreme cold to destroy fat cells and stimulate collagen production. This treatment can be effective for NPLL, but multiple sessions may be required to achieve optimal results.
21. Mesotherapy: Mesotherapy involves the injection of a customized cocktail of vitamins, minerals, and other nutrients into the skin. This treatment can improve the texture and appearance of the skin and stimulate collagen production.
22. Thread lift: A thread lift involves the use of dissolvable threads to lift and tighten the skin. This can be an effective treatment for NPLL, but the results may not be as dramatic as those achieved with other treatments.

References